Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05837819 · ClinicalTrials.gov registry record · NA
Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 135
- Enrollment target
NCT05837819 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 135 participants.
The verdict
NCT05837819, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 135 participants
- Enrollment target
Study Summary
Aim 2 will investigate the effect of 3 different light exposure lengths on sleep, mood and agitation in persons with Alzheimer's disease. Participants will be randomly assigned to one of three conditions of light exposure: 1) 2-h morning light exposure; 2) 4-h morning light exposure; and 3) all day light exposure.
Interventions
- DEVICE Active Lighting Intervention
- DEVICE Control Lighting Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2023-02-14 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05837819
The ClinicalTrials.gov registry entry for NCT05837819 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active Lighting Intervention is the first listed.
NCT05837819 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05837819 about?
NCT05837819 is a clinical study titled "Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2". Aim 2 will investigate the effect of 3 different light exposure lengths on sleep, mood and agitation in persons with Alzheimer's disease. Participants will be randomly assigned to one of three conditions of light exposure: 1) 2-h morning light exposure; 2) 4-h morning light exposure; and 3) all day ...
What is the current status of trial NCT05837819?
This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2023-02-14. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT05837819?
The interventions under investigation include: Active Lighting Intervention (DEVICE), Control Lighting Intervention (DEVICE).
Who is sponsoring clinical trial NCT05837819?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.